Terminal latency index in polyneuropathy with IgM paraproteinemia and anti-mag antibody

Muscle and Nerve

Volumn 24, Issue 10, 2001, Pages 1278-1282

  Cocito, Dario ^a   Isoardo, Gianluca ^a   Ciaramitaro, Palma ^a   Migliaretti, Giuseppe ^a   Pipieri, Antonio ^a   Barbero, Pierangelo ^a   Cucci, Angele ^a   Durelli, Luca ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Anti MAG antibody; Chronic inflammatory demyelinating polyneuropathy; Paraproteinemia; Terminal latency index

Indexed keywords

IMMUNOGLOBULIN M; MYELIN ASSOCIATED GLYCOPROTEIN; PROTEIN ANTIBODY;

ADULT; AGED; ARTICLE; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; ELECTROPHYSIOLOGY; FEMALE; HUMAN; LATENT PERIOD; MALE; MEDIAN NERVE; MOTOR NERVE; NERVE CONDUCTION; PARAPROTEINEMIA; POLYNEUROPATHY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TERMINAL LATENCY INDEX; ULNAR NERVE;

AGED; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; MOTOR NEURONS; MYELIN-ASSOCIATED GLYCOPROTEIN; NEURAL CONDUCTION; PARAPROTEINEMIAS; POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING; REACTION TIME; SENSITIVITY AND SPECIFICITY; WALDENSTROM MACROGLOBULINEMIA;

EID: 0034814774     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/mus.1145     Document Type: Article

References (18)

1. Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP)
2. Tomaculous neuropathy: A clinical and electrophysiological study in patients with and without 1.5-Mb deletions in chromosome 17p11.2
3. Waldenström macroglobulinemia: Clinical features, complications and management
4. Neuropathy associated with "benign" anti-myelin-associated glycoprotein IgM gammopathy: Clinical, immunological, neurophysiological, pathological findings and response to treatment in 33 cases
5. User's guide to the medical literature. III. How to use an article about a diagnostic test B. What are the results and will they help me in caring for my patients?
6. Distal accentuation of conduction slowing in polyneuropathy associated with antibodies to myelin-associated glycoprotein and sulphated glucuronyl paragloboside
7. Distal acquired demyelinating symmetric neuropathy
8. Chronic dysimmune demyelinating polyneuropathy: A clinical and electrophysiological study of 93 patients
9. Anti-myelin associated glycoprotein IgM antibody titers in neuropathy associated with macroglobulinemia
10. Long term prognosis of neuropathy associated with anti-MAG IgM M-proteins and its relationship to immune therapies
11. Diagnostic criteria for demyelinating polyneuropathy associated with monoclonal gammopathy
12. Neuropathies associated with paraproteinemia
13. The spectrum of chronic inflammatory demyelinating polyneuropathy
14. A prime on the precision and accuracy of the clinical examination
15. Anti-SGPG antibody in CIDP: Nosological position of IgM anti-MAG/SGPG antibody-associated neuropathy
16. Motor conduction parameters in neuropathies associated with anti-MAG antibodies and other types of demyelinating and axonal neuropathies
17. Development of weakness in patients with chronic inflammatory demyelinating polyneuropathy and only sensory symptoms at presentation: A long term follow-up study